Tecentriq Copay Assistance

지원 작동 방식

비교할 수 없는 완벽한 편의성을 통해 환자의 전문 약국 경험을 간소화합니다.

1. 보장 범위/혜택 확인

당사의 전문 청구자 팀은 실제 비용을 최소화하는 가장 적합한 보장 방안을 찾아드립니다.
2. AmeriPharma®로 처방전 전송

우리는 귀하의 이전 약국이나 처방자와 협력하여 처방을 처리하므로 전환이 빠르고 쉽습니다.
3. 사전 승인

저희 전문가 팀은 24~72시간 내에 귀하의 보험 회사로부터 승인을 받습니다.
4. 공제금 지원 및 재정 지원

저희는 재정 지원을 확보하고 본인 부담금, 본인 부담금, 그리고 높은 공제액을 줄여드립니다. 현재까지 AmeriPharma® Specialty Care는 환자분들을 위해 1TP4억 4,700만 달러(약 1,447억 5,500만 원)의 재정 지원을 확보했습니다.
5. 필요한 경우 간호 관리 조정

AmeriPharma®는 집에서 주입을 위해 전문 간호사 중 한 명과 일정을 조정하고 조정할 때 귀하의 일정과 가정 환경을 우선시합니다.
6. 배송 조정

의약품은 항상 특정 배송 요건을 엄격히 준수하여 배송됩니다. 익일 배송 및 익일 배송은 고객님의 일정에 맞춰 조정됩니다.

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/pharmacist.jpg

What Is Tecentriq?

Tecentriq (atezolizumab) is a chemotherapy medication that’s used for the treatment of certain types of metastatic (spread to other parts of the body) or unresectable (untreatable with surgery) cancer (e.g., lung cancer, liver cancer, melanoma, and alveolar soft part sarcoma). It can be used by itself, or it can be used together with other chemotherapy medications, depending on the type of cancer and how severe it is. Tecentriq was given accelerated approval in March 2019 by the U.S. 식품의약국.

How Does Tecentriq Work?

Tecentriq is known as an immune checkpoint inhibitor. The immune system has checkpoints, which are proteins on cells that help control how well your immune system works. Cancer cells can sometimes use these checkpoints to hide from the immune system, which makes it harder for the immune system to find and attack cancer cells. Tecentriq blocks a protein called PD-L1 (an immune checkpoint) on cancer cells from working. This allows the T cells of your immune system to fight and attack the cancer cells.

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block_image_1.jpg

What is Tecentriq Used For?

Tecentriq is approved to treat the following types of cancer:

Non-small cell lung cancer (NSCLC): Tecentriq is used alone or together with other chemotherapy, depending on the type of NSCLC and how severe it is.
Small cell lung cancer: Tecentriq is used together with carboplatin or etoposide.
Hepatocellular carcinoma: Tecentriq is used with bevacizumab in people who haven’t previously received chemotherapy.
Melanoma: Tecentriq is used with cobimetinib and vemurafenib in people with a specific type of melanoma called BRAF-V600 mutation-positive melanoma.
Alveolar soft part sarcoma (ASPS): Tecentriq is used alone for treatment in adults and children aged 2 years and older with ASPS.

공제금 및 재정 지원

AmeriPharma™ 전문 약국은 환자와 그 가족의 재정적 부담을 덜어줍니다.

고급 소프트웨어는 귀하에게 최고 수준의 재단 프로그램을 매칭하기 위해 자금원을 찾아줍니다.
당사의 공제금 지원 전문가 중 한 명이 신청 절차를 도와드립니다.
자금 지원 상태에 대한 자동 업데이트가 귀하와 귀하의 의사에게 전송됩니다.

https://ameripharmaspecialty.com/wp-content/uploads/2024/05/doctor-patient.jpg

Direction for Use

In general, the dose of Tecentriq is either 840 mg every 2 weeks, 1,200 mg every 3 weeks, or 1,680 mg every 4 weeks. For children 2 years of age and older using Tecentriq for ASPS, the typical dose is 15 mg/kg of body weight (up to 1,200 mg) every 3 weeks. If you’re having side effects from the medication, your healthcare provider will adjust your dose.

Tecentriq is given as an infusion into the veins by a trained healthcare professional. The first infusion is given over 1 hour. If the first infusion is tolerated well, the following infusions can be given over 30 minutes instead.

The length of time you need to be on Tecentriq will depend on the type of cancer. For example, people with metastatic NSCLC and ASPS typically continue to receive Tecentriq until the cancer has progressed and worsened or until they’re no longer tolerating the medication.

Tecentriq Side Effects

The most common side effects reported in people taking Tecentriq include:

Fatigue (48%)
Low appetite (25%)
Nausea (24%)
Cough (22%)
Shortness of breath (22%)

Other possible side effects include:

Skin reactions (e.g., rash, itching, blisters)
두통
감염
Joint or muscle pain

Tecentriq can also damage some of your organs and make them not work as well. The medication can cause lung, kidney, liver, colon, hormone gland, adrenal gland, and thyroid inflammation. It can also raise your liver enzymes, which could potentially lead to liver problems. The medication can also cause low thyroid hormone levels and low blood cell counts, which raises your risk for infections. Your provider will likely draw labs during treatment with Tecentriq to monitor and make sure the medication isn’t damaging your organs. Make sure to tell your provider about all of your medical problems before starting Tecentriq to ensure the medication is as safe for you as possible.

Talk to your provider if you’re pregnant, thinking of becoming pregnant, or breastfeeding before or during treatment with Tecentriq. This is because the medication can potentially cause harm to babies when taken by pregnant or breastfeeding mothers.